Key result
Cholesterol-enriched human platelets released significantly more arachidonic acid (18.1% vs 14.6%, P<0.001) and converted more to thromboxane B2 than cholesterol-depleted platelets in vitro.
Why the study?
Does cholesterol enrichment increase arachidonic acid metabolism and thromboxane B2 production in human platelets in vitro?
Population
Human platelets in vitro
Comparison
Incubation with "cholesterol-rich" liposomes vs Incubation with "cholesterol-poor" liposomes
Design
Preclinical
Authors
Loading...
May enhance platelet reactivity in hypercholesterolemia; hypothesis-generating and should not yet change practice.
Does cholesterol enrichment increase arachidonic acid metabolism and thromboxane B2 production in human platelets in vitro?
Absolute Event Rate: 18.1% vs 14.6%
p-value: p=<0.001
In vitro cholesterol enrichment of human platelets significantly increases arachidonic acid release and thromboxane B2 production, providing a mechanistic link between cholesterol levels and platelet reactivity.
Stuart et al. (1980) studied Platelet metabolism. Cholesterol-rich liposomes vs. Cholesterol-poor liposomes was evaluated on Release of [14C]arachidonic acid from prelabeled platelet phospholipids after addition of thrombin (p=<0.001). Cholesterol-enriched human platelets released significantly more arachidonic acid (18.1% vs 14.6%, P<0.001) and converted more to thromboxane B2 than cholesterol-depleted platelets in vitro.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: